NANBV diagnostics and vaccines
US6150087A · kind A · utility
43Cited by
6References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 1995 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | May 18, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
We have discovered epitopes of the HCV viral proteins which are immunoreactive with immune serum. The epitopes are useful in immunodiagnostic assays and as immunogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.